+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Australia Cardiac Disease Market Outlook to 2036 - Cardiac Marker Tests

  • PDF Icon

    Report

  • 63 Pages
  • May 2026
  • Region: Australia
  • GlobalData
  • ID: 6108354

Australia Cardiac Disease Market Outlook to 2036 - Cardiac Marker Tests

Summary

The analyst’s “Australia Cardiac Disease Market Outlook to 2036” is a comprehensive databook report, covering key market data on the Australia Cardiac Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Marker Tests

The Australia Cardiac Disease Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
  • 2025 company share data for Cardiac Disease Market.
  • Global corporate-level profiles of key companies operating within the Australia Cardiac Disease Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Australia Cardiac Disease is segmented as follows:

  • Cardiac Marker Tests

Reasons to Buy

The Australia Cardiac Disease Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Introduction
1.1 What Is This Report About?
1.2 Cardiac Disease Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Cardiac Disease Market, Australia
2.1 Cardiac Disease Market, Australia, Revenue ($m), 2024-2036
2.1.1 Cardiac Marker Tests Market, Australia, Revenue ($m), by Segment, 2024-2036
2.2 Cardiac Disease Market, Australia, Volume (Units), 2024-2036
2.2.1 Cardiac Marker Tests Market, Australia, Volume (Units), by Segment, 2024-2036
2.3 Cardiac Disease Market, Australia, Average Price ($), 2024-2036
2.4 Cardiac Disease Market, Australia, Company Share by Revenue ($m), 2025
3 Cardiac Disease Market Pipeline Products
3.1 Cardiac Disease Market Pipeline Products
3.2 Cardiac Disease - Pipeline Products by Stage of Development
3.3 Cardiac Disease - Pipeline Products by Segment
3.4 Cardiac Disease - Pipeline Products by Territory
3.5 Cardiac Disease - Pipeline Products by Regulatory Path
3.6 Cardiac Disease - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in Australia, Cardiac Disease Market
4.1 Abbott Laboratories
4.1.1 Company Overview
4.2 F. Hoffmann-La Roche Ltd
4.2.1 Company Overview
4.3 Beckman Coulter Inc
4.3.1 Company Overview
4.4 Siemens Healthineers AG
4.4.1 Company Overview
4.5 Quidel Corp
4.5.1 Company Overview
4.6 bioMerieux SA
4.6.1 Company Overview
5 Recent Developments
5.1 Corporate Communications
5.1.1 Oct 21, 2025: University of Paris-Saclay Establishes New Strategic Orientation Council Led by Geneviève Berger
5.2 Product News
5.2.1 Mar 12, 2026: PsyMetRiC: Tool to Predict Physical Health Risks in Young People With Psychosis
5.2.2 Nov 13, 2025: New Gene Discoveries Enhance Diagnosis of Inherited Heart Disease
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the Analyst Consulting
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Cardiac Disease Market, Australia, Revenue ($m), USD Constant, 2024-2036
Table 2: Cardiac Marker Tests Market, Australia, Revenue ($m), USD Constant, 2024-2036
Table 3: Cardiac Disease Market, Australia, Volume (Units), 2024-2036
Table 4: Cardiac Marker Tests Market, Australia, Volume (Units), 2024-2036
Table 5: Cardiac Disease Market, Australia, Average Price ($), 2024-2036
Table 6: Cardiac Disease Market, Australia, Company Share by Revenue ($m), USD Constant, 2025
Table 7: Cardiac Disease Market Pipeline Products
Table 8: Cardiac Disease - Pipeline Products by Stage of Development
Table 9: Cardiac Disease Companies - Pipeline Products by Stage of Development
Table 10: Cardiac Disease - Pipeline Products by Segment
Table 11: Cardiac Disease - Pipeline Products by Territory
Table 12: Cardiac Disease - Pipeline Products by Regulatory Path
Table 13: Cardiac Disease - Pipeline Products by Estimated Approval Date
Table 14: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Cardiac Disease Market, Australia, Revenue ($m), USD Constant, 2024-2036
Figure 2: Cardiac Marker Tests Market, Australia, Revenue ($m), USD Constant, 2024-2036
Figure 3: Cardiac Disease Market, Australia, Volume (Units), 2024-2036
Figure 4: Cardiac Marker Tests Market, Australia, Volume (Units), 2024-2036
Figure 5: Cardiac Disease Market, Australia, Company Share (%), 2025
Figure 6: Cardiac Disease - Pipeline Products by Stage of Development
Figure 7: Cardiac Disease - Pipeline Products by Segment
Figure 8: Cardiac Disease - Pipeline Products by Territory
Figure 9: Cardiac Disease - Pipeline Products by Regulatory Path
Figure 10: Cardiac Disease - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Beckman Coulter Inc
  • Siemens Healthineers AG
  • Quidel Corp
  • bioMerieux SA